| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-009923 |
| cik | 1022899 |
| name | PROTAGENIC THERAPEUTICS, INC.NEW |
| sic | 2834 |
| countryba | US |
| stprba | NY |
| cityba | NEW YORK |
| zipba | 10010 |
| bas1 | 149 FIFTH AVENUE |
| bas2 | SUITE 500 |
| baph | (212) 994-8200 |
| countryma | US |
| stprma | NY |
| cityma | NEW YORK |
| zipma | 10010 |
| mas1 | 149 FIFTH AVENUE |
| mas2 | SUITE 500 |
| countryinc | US |
| stprinc | DE |
| ein | 061390025 |
| former | ATRINSIC, INC. |
| changed | 20090630 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250513 |
| accepted | 2025-05-13 15:22:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009923 | 20241231 | Accounts Payable And Accrued Liabilities Current | 39875.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-009923 | 20250331 | Additional Paid In Capital | 37784699.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Earnings Per Share Basic | -5.4400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | General And Administrative Expense | 277613.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20240331 | Net Cash Provided By Used In Operating Activities | -1659185.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20250331 | Operating Expenses | 1448108.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | 192.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Loss Net Unrealized Loss On Marketable Securities | 26587.0000 | USD | 1 | 0001641172-25-009923 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | 26587.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | 26587.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Authorized | 18000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Realized Gain Loss On Marketable Securities | USD | 1 | 0001641172-25-009923 | ||||
| 0001641172-25-009923 | 20231231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20241231 | Shares Outstanding | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | 34559502.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | 33.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | -30777872.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | 54.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | 395474.0000 | USD | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-009923 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 316804.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 161861.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 236014.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Common Stock Shares Outstanding | 517257.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Common Stock Value | 54.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Earnings Per Share Diluted | -5.4400 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 190.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -11.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20241231 | Liabilities | 942759.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Operating Expenses | 1738359.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -11.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Preferred Stock; | |||
| 0001641172-25-009923 | 20241231 | Property Plant And Equipment Net | 73046.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Realized Gain Loss On Sale Of Marketable Securities | -198.0000 | USD | 1 | 0001641172-25-009923 | |||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | 1013154.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | -36303216.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 523185.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 236014.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Assets | 988650.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Assets Current | 1882867.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -456115.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Common Stock Shares Issued | 517257.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Common Stock Shares Issued | 537549.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Common Stock Shares Outstanding | 537549.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Earnings Per Share Diluted | -2.7500 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -1440005.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20240331 | Increase Decrease In Prepaid Expense | -100031.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Net Cash Provided By Used In Operating Activities | -1068017.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Income Loss | -1724294.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20250331 | Net Income Loss | -1440005.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | 192.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Authorized | 18000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Proceeds From Issuance Of Warrants | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20231231 | Shares Outstanding | 316804.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20240331 | Shares Outstanding | 316804.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Shares Outstanding | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | 3668117.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20250331 | Unrealized Gain Or Loss On Marketable Securities | USD | 1 | 0001641172-25-009923 | ||||
| 0001641172-25-009923 | 20250331 | Accounts Payable And Accrued Liabilities Current | 1076979.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009923 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | -129850.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20250331 | Depreciation | 12572.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Increase Decrease In Accounts Payable And Accrued Expenses Related Party | USD | 1 | 0001641172-25-009923 | ||||
| 0001641172-25-009923 | 20250331 | Investment Income Interest | 8103.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Liabilities | 1076979.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Liabilities And Stockholders Equity | 988650.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Liabilities Current | 942759.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Net Cash Provided By Used In Financing Activities | 102519.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20250331 | Operating Income Loss | -1448108.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Payments To Acquire Marketable Securities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Preferred Stock; | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | |||
| 0001641172-25-009923 | 20241231 | Prepaid Expense Current | 44398.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Research And Development Expense | 0.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Research Agreements; | ||
| 0001641172-25-009923 | 20250331 | Share Based Compensation | 236014.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | 2132463.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | -37743221.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Shares Other | 11.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | |||
| 0001641172-25-009923 | 20241231 | Assets | 1955913.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Cash | 872960.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 872960.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Increase Decrease In Accounts Payable And Accrued Expenses Related Party | -39875.0000 | USD | 1 | 0001641172-25-009923 | |||
| 0001641172-25-009923 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 174095.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Liabilities Current | 1076979.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Income Loss | -1724294.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20250331 | Net Income Loss | -1440005.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Nonoperating Income Expense | 14065.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Nonoperating Income Expense | 8103.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Operating Income Loss | -1738359.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | 192.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | -11.0000 | USD | 1 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Authorized | 2000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Proceeds From Issuance Of Warrants | 102519.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 1500000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Property Plant And Equipment Net | 60474.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Research And Development Expense | 1460746.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Retained Earnings Accumulated Deficit | -36303216.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Shares Outstanding | 537549.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Stock Issued During Period Shares New Issues | 0.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 523185.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Share Based Compensation | 161861.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Accounts Payable And Accrued Liabilities Current | 902884.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009923 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | -129861.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -965509.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Comprehensive Income Net Of Tax | -1697515.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Comprehensive Income Net Of Tax | -1440016.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | General And Administrative Expense | 567736.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Increase Decrease In Prepaid Expense | 10818.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Liabilities And Stockholders Equity | 1955913.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20240331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Prepaid Expense Current | 55216.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Realized Gain Loss On Sale Of Marketable Securities | USD | 1 | 0001641172-25-009923 | ||||
| 0001641172-25-009923 | 20240331 | Shares Outstanding | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | 33.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | -129850.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | 52.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Shares New Issues | 51203.0000 | shares | 0 | us-gaap/2024 | Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | 102519.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | 2.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20240331 | Unrealized Gain Or Loss On Marketable Securities | 26587.0000 | USD | 1 | 0001641172-25-009923 | |||
| 0001641172-25-009923 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 316804.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Accounts Payable And Accrued Liabilities Current | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | |||
| 0001641172-25-009923 | 20241231 | Additional Paid In Capital | 37446168.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20241231 | Cash | 1838469.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1287893.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 831778.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 1838469.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Depreciation | 12572.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Earnings Per Share Basic | -2.7500 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -1724294.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -209157.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Cash Provided By Used In Investing Activities | 1202880.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Net Cash Provided By Used In Investing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Loss Net Unrealized Loss On Marketable Securities | USD | 1 | 0001641172-25-009923 | ||||
| 0001641172-25-009923 | 20240331 | Payments To Acquire Marketable Securities | 297120.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Authorized | 2000000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Research And Development Expense | 0.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Research Agreements; | ||
| 0001641172-25-009923 | 20250331 | Retained Earnings Accumulated Deficit | -37743221.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | 34721363.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | -32502166.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009923 | 20241231 | Stockholders Equity | 37446168.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | -88329.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | -129861.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Shares New Issues | 20303.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 161861.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20250331 | Assets Current | 928176.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Common Stock Value | 52.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Investment Income Interest | 13867.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20240331 | Net Cash Provided By Used In Financing Activities | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009923 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-009923 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | -11.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Authorized | 20000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | ||
| 0001641172-25-009923 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001641172-25-009923 | 20250331 | Preferred Stock Value | USD | 0 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; | |||
| 0001641172-25-009923 | 20240331 | Realized Gain Loss On Marketable Securities | -198.0000 | USD | 1 | 0001641172-25-009923 | |||
| 0001641172-25-009923 | 20250331 | Research And Development Expense | 880372.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009923 | 20241231 | Shares Outstanding | 517257.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009923 | 20231231 | Stockholders Equity | -113546.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20240331 | Stockholders Equity | -86767.0000 | USD | 0 | us-gaap/2024 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001641172-25-009923 | 20250331 | Stockholders Equity | 37784699.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value New Issues | 102517.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009923 | 20250331 | Stock Issued During Period Value Other | USD | 1 | us-gaap/2024 | Class Of Stock= Series B Convertible Preferred Stock; Equity Components= Preferred Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax | Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | D | D | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Realized Gain Loss On Marketable Securities | 0001641172-25-009923 | 1 | 0 | monetary | D | D | RealizedGainLossOnMarketableSecurities | Realized gain loss on marketable securities. |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Increase Decrease In Prepaid Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense | The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Increase Decrease In Accounts Payable And Accrued Expenses Related Party | 0001641172-25-009923 | 1 | 0 | monetary | D | D | Accounts payable and accrued expenses related party | Accounts payable and accrued expenses related party. |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Realized Gain Loss On Sale Of Marketable Securities | 0001641172-25-009923 | 1 | 0 | monetary | D | D | Realized gain on sale of marketable securities | Realized gain loss on sale of marketable securities. |
| Unrealized Gain Or Loss On Marketable Securities | 0001641172-25-009923 | 1 | 0 | monetary | D | C | UnrealizedGainOrLossOnMarketableSecurities | Unrealized gain or loss on marketable securities |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Stock Issued During Period Shares Other | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Other Comprehensive Income Loss Net Unrealized Loss On Marketable Securities | 0001641172-25-009923 | 1 | 0 | monetary | D | C | Net unrealized gain on marketable securities | Other comprehensive income loss net unrealized loss on marketable securities. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Proceeds From Issuance Of Warrants | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Investment Income Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Investment Income, Interest | Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Payments To Acquire Marketable Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Value Other | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009923 | 2 | 13 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001641172-25-009923 | 2 | 14 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expenses | 0 |
| 0001641172-25-009923 | 2 | 15 | BS | 0 | H | Assets Current | us-gaap/2024 | TOTAL CURRENT ASSETS | 0 |
| 0001641172-25-009923 | 2 | 16 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Equipment - net | 0 |
| 0001641172-25-009923 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | TOTAL ASSETS | 0 |
| 0001641172-25-009923 | 2 | 20 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-009923 | 2 | 21 | BS | 0 | H | Liabilities Current | us-gaap/2024 | TOTAL CURRENT LIABILITIES | 0 |
| 0001641172-25-009923 | 2 | 22 | BS | 0 | H | Liabilities | us-gaap/2024 | TOTAL LIABILITIES | 0 |
| 0001641172-25-009923 | 2 | 24 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, value | 0 |
| 0001641172-25-009923 | 2 | 25 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, $.0001 par value, 100,000,000 shares authorized, 537,549 and 517,257 shares issued and outstanding at March 31, 2025, and December 31, 2024 | 0 |
| 0001641172-25-009923 | 2 | 26 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in-capital | 0 |
| 0001641172-25-009923 | 2 | 27 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-009923 | 2 | 28 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Accumulated other comprehensive loss | 0 |
| 0001641172-25-009923 | 2 | 29 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | TOTAL STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-009923 | 2 | 30 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | 0 |
| 0001641172-25-009923 | 3 | 9 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-009923 | 3 | 10 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-009923 | 3 | 11 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-009923 | 3 | 12 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-009923 | 3 | 13 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-009923 | 3 | 14 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-009923 | 3 | 15 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-009923 | 3 | 16 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-009923 | 4 | 2 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-009923 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-009923 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | TOTAL OPERATING AND ADMINISTRATIVE EXPENSES | 0 |
| 0001641172-25-009923 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | LOSS FROM OPERATIONS | 0 |
| 0001641172-25-009923 | 4 | 7 | IS | 0 | H | Investment Income Interest | us-gaap/2024 | Interest income | 0 |
| 0001641172-25-009923 | 4 | 8 | IS | 0 | H | Realized Gain Loss On Marketable Securities | 0001641172-25-009923 | Realized loss on marketable securities | 1 |
| 0001641172-25-009923 | 4 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | TOTAL OTHER INCOME | 0 |
| 0001641172-25-009923 | 4 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | LOSS BEFORE TAX | 0 |
| 0001641172-25-009923 | 4 | 11 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | INCOME TAX EXPENSE | 0 |
| 0001641172-25-009923 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | NET LOSS | 0 |
| 0001641172-25-009923 | 4 | 15 | IS | 0 | H | Other Comprehensive Income Loss Net Unrealized Loss On Marketable Securities | 0001641172-25-009923 | Net unrealized gain on marketable securities | 0 |
| 0001641172-25-009923 | 4 | 16 | IS | 0 | H | Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | us-gaap/2024 | Foreign exchange translation income (loss) | 0 |
| 0001641172-25-009923 | 4 | 17 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | TOTAL COMPREHENSIVE LOSS | 0 |
| 0001641172-25-009923 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per common share - Basic | 0 |
| 0001641172-25-009923 | 4 | 19 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per common share - Diluted | 0 |
| 0001641172-25-009923 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average common shares - Basic | 0 |
| 0001641172-25-009923 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average common shares - Diluted | 0 |
| 0001641172-25-009923 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009923 | 5 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009923 | 5 | 15 | EQ | 0 | H | Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | us-gaap/2024 | Foreign currency translation gain | 0 |
| 0001641172-25-009923 | 5 | 16 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax | us-gaap/2024 | Unrealized gain on marketable securities | 0 |
| 0001641172-25-009923 | 5 | 17 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock compensation - stock options | 0 |
| 0001641172-25-009923 | 5 | 18 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009923 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Stock issued for cash | 0 |
| 0001641172-25-009923 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock issued for cash, shares | 0 |
| 0001641172-25-009923 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Value Other | us-gaap/2024 | Rounding from reverse split | 0 |
| 0001641172-25-009923 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Shares Other | us-gaap/2024 | Rounding from reverse split, shares | 1 |
| 0001641172-25-009923 | 5 | 23 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009923 | 5 | 24 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009923 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net Loss | 0 |
| 0001641172-25-009923 | 6 | 4 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation expense | 0 |
| 0001641172-25-009923 | 6 | 5 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001641172-25-009923 | 6 | 6 | CF | 0 | H | Realized Gain Loss On Sale Of Marketable Securities | 0001641172-25-009923 | Realized gain on sale of marketable securities | 0 |
| 0001641172-25-009923 | 6 | 8 | CF | 0 | H | Increase Decrease In Prepaid Expense | us-gaap/2024 | Prepaid expenses | 1 |
| 0001641172-25-009923 | 6 | 9 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-009923 | 6 | 10 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Expenses Related Party | 0001641172-25-009923 | Accounts payable and accrued expenses related party | 0 |
| 0001641172-25-009923 | 6 | 11 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | NET CASH USED IN OPERATING ACTIVITIES | 0 |
| 0001641172-25-009923 | 6 | 13 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2024 | Proceeds from sale of marketable securities | 0 |
| 0001641172-25-009923 | 6 | 14 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2024 | Purchase of marketable securities | 1 |
| 0001641172-25-009923 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | NET CASH PROVIDED BY INVESTING ACTIVITIES | 0 |
| 0001641172-25-009923 | 6 | 17 | CF | 0 | H | Proceeds From Issuance Of Warrants | us-gaap/2024 | Issuance of shares from offering, net of offering costs | 0 |
| 0001641172-25-009923 | 6 | 18 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | NET CASH PROVIDED BY FINANCING ACTIVITIES | 0 |
| 0001641172-25-009923 | 6 | 19 | CF | 0 | H | Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Effect of exchange rate changes on cash | 0 |
| 0001641172-25-009923 | 6 | 20 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | NET CHANGE IN CASH | 0 |
| 0001641172-25-009923 | 6 | 21 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH, BEGINNING OF THE PERIOD | 0 |
| 0001641172-25-009923 | 6 | 22 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | CASH, END OF THE PERIOD | 0 |
| 0001641172-25-009923 | 6 | 24 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest expense | 0 |
| 0001641172-25-009923 | 6 | 25 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income taxes | 0 |
| 0001641172-25-009923 | 6 | 27 | CF | 0 | H | Unrealized Gain Or Loss On Marketable Securities | 0001641172-25-009923 | Unrealized gain on marketable securities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |